| | | |
EA/transVA
|
transVA/cisVA
|
|---|
|
Protein name
|
Uniprot name
|
spot no
|
Av. Ratio
|
p-value
|
Av. Ratio
|
p-value
|
|---|
|
14-3-3 protein zeta/delta
|
1433Z/P63104
|
2180
| | |
−1.43
|
3.0E-02
|
|
Aldose 1-epimerase
|
GALM/Q96C23
|
1832
|
2
|
2.5E-03
| | |
|
Alpha-1-antitrypsin
|
A1AT/P01009
|
1330
|
1.79
|
3.6E-04
| | |
|
Alpha-1-antitrypsin
| |
1342
|
1.96
|
3.9E-03
| | |
|
Alpha-2-HS-glycoprotein
|
FETUA/P02765
|
1400
|
−1.51
|
3.4E-02
| | |
|
Apolipoprotein A1
|
APOA1/P02647
|
2333
|
1.57
|
2.0E-04
| | |
|
Apolipoprotein A4
|
APOA4/P06727
|
1737
|
1.57
|
7.3E-03
|
1.39
|
4.8E-02
|
|
Apolipoprotein A4
| |
1741
|
1.7
|
1.7E-04
|
1.4
|
2.8E-03
|
|
Apolipoprotein A4
| |
1743
|
1.43
|
2.3E-02
| | |
|
Apolipoprotein E
|
APOE/P02649
|
2030
|
1.39
|
5.9E-03
| | |
|
Carboxypeptidase E
|
CBPE/P16870
|
1417
|
−1.78
|
1.3E-03
| | |
|
Chloride intracellular channel protein1
|
CLIC1/O00299
|
2106
|
1.75
|
1.9E-03
| | |
|
Complement C3
|
CO3/P01024
|
1675
|
−1.41
|
3.1E-02
| | |
|
Complement C3
| |
1706
|
−1.51
|
4.6E-03
| | |
|
Complement C3
| |
1708
|
−1.51
|
4.6E-03
| | |
|
Complement C3
| |
1710
|
−1.51
|
8.8E-04
| | |
|
Complement factor B
|
CFAB/P00751
|
726
|
−1.32
|
2.5E-03
| | |
|
Endoplasmin
|
ENPL/P14625
|
737
|
−1.51
|
4.8E-02
| | |
|
Proteasome subunit alpha type-5
|
PSA5/P28066
|
2203
| | |
−1.37
|
4.7E-02
|
|
Protein AMBP
|
AMBP/P02760
|
2042
|
1.62
|
2.2E-03
| | |
|
Serotransferrin
|
TRFE/P02787
|
1005
|
1.56
|
8.0E-04
| | |
|
Serotransferrin
| |
1007
|
2.02
|
2.7E-04
| | |
|
Serotransferrin
| |
1033
|
1.65
|
1.5E-04
| | |
|
Serotransferrin
| |
1765
|
1.43
|
1.1E-02
| | |
- The secretome of hepatocytes supplemented with transVA, EA, or cisVA were analyzed by DIGE and subsequently the regulated proteins were identified by LC-MS/MS analyses. In the table proteins are reported with protein name, Uniprot name/accession number, 2D gel spot number (spot no), Average ratio (Av.ratio), and p-value for individual comparisons
